Quintiles, the world's largest clinical research organisation, recently organised a media round table on the biosimilars (generic biologics) landscape with senior executives in Mumbai. Here are the key points, including figures, that emerged out of the discussion: -An estimated 277 companies are developing biosimilars worldwide. A company developing a biosimilar may not be fully aware … Continue reading 5 takeaways from Quintiles’ media round-table on biosimilars
